The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Dipeptidyl Peptidase-4 Inhibition and the Treatment of Type 2 Diabetes
Open accessAbstract
INACTIVATION OF INCRETIN HORMONES-Circulating levels of DPP-4 activity have been reported to be higher in some studies of subjects with chronic hyperglycemia and type 2 diabetes (9,10); however, whether circulating DPP-4 activity correlates with the levels of active plasma GLP-1 in individual human subjects is not known.The observation that DPP-4 was capable of cleaving the incretin peptides GIP and GLP-1 in human serum in vitro, together with the
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MENTLEIN, R., GALLWITZ, B., & SCHMIDT, W. E. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17986.x · Cited by 1,161
Kieffer, T. J., McIntosh, C. H., & Pederson, R. A. (1995) · Endocrinology · doi:10.1210/endo.136.8.7628397 · Cited by 1,124
Winzell, M. S., & Ahrén, B. (2004) · Diabetes · doi:10.2337/diabetes.53.suppl_3.s215 · Cited by 1,026
Lambeir, A.-M., Durinx, C., Scharpé, S., & De Meester, I. (2003) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/713609354 · Cited by 955
Deacon, C. F., Nauck, M. A., Toft-Nielsen, M., Pridal, L., Willms, B., & Holst, J. J. (1995) · Diabetes · doi:10.2337/diab.44.9.1126 · Cited by 878
Deacon, C. F., Johnsen, A. H., & Holst, J. J. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.3.7883856 · Cited by 792
Charbonnel, B., Karasik, A., Liu, J., Wu, M., Meininger, G., & for the Sitagliptin Study 020 Group (2006) · Diabetes Care · doi:10.2337/dc06-0706 · Cited by 790
Enhanced insulin secretion and improved glucose tolerance in mice lacking CD26
Marguet, D., Baggio, L., Kobayashi, T., Bernard, A.-M., Pierres, M., Nielsen, P. F., Ribel, U., Watanabe, T., Drucker, D. J., & Wagtmann, N. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.120069197 · Cited by 538
Self-citationDipeptidyl Peptidase IV Inhibition for the Treatment of Type 2 Diabetes
Lankas, G. R., Leiting, B., Roy, R. S., Eiermann, G. J., Beconi, M. G., Biftu, T., Chan, C.-C., Edmondson, S., Feeney, W. P., He, H., et al. (2005) · Diabetes · doi:10.2337/diabetes.54.10.2988 · Cited by 491
Modulation of hematopoietic stem cell homing and engraftment by CD26
Christopherson, K. W., Hangoc, G., Mantel, C. R., & Broxmeyer, H. E. (2004) · Science · doi:10.1126/science.1097071 · Cited by 452
Mu, J., Woods, J., Zhou, Y.-P., Roy, R. S., Li, Z., Zycband, E., Feng, Y., Zhu, L., Li, C., Howard, A. D., et al. (2006) · Diabetes · doi:10.2337/db05-1602 · Cited by 449
The structure and function of CD26 in the T‐cell immune response
Morimoto, C., & Schlossman, S. F. (1998) · Immunological Reviews · doi:10.1111/j.1600-065x.1998.tb01571.x · Cited by 421
Deacon, C. F., Nauck, M. A., Meier, J., Hücking, K., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.10.6855 · Cited by 401
Mari, A., Sallas, W. M., He, Y. L., Watson, C., Ligueros-Saylan, M., Dunning, B. E., Deacon, C. F., Holst, J. J., & Foley, J. E. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-2460 · Cited by 361
Mice lacking dipeptidyl peptidase IV are protected against obesity and insulin resistance
Conarello, S. L., Li, Z., Ronan, J., Roy, R. S., Zhu, L., Jiang, G., Liu, F., Woods, J., Zycband, E., Moller, D. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0631828100 · Cited by 347
Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders
GORRELL, M. D. (2005) · Clinical Science · doi:10.1042/cs20040302 · Cited by 334
Pospisilik, J. A., Martin, J., Doty, T., Ehses, J. A., Pamir, N., Lynn, F. C., Piteau, S., Demuth, H.-U., McIntosh, C. H. S., & Pederson, R. A. (2003) · Diabetes · doi:10.2337/diabetes.52.3.741 · Cited by 332
Deacon, C. F., Hughes, T. E., & Holst, J. J. (1998) · Diabetes · doi:10.2337/diabetes.47.5.764 · Cited by 321
Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes
Pi-Sunyer, F. X., Schweizer, A., Mills, D., & Dejager, S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2006.12.009 · Cited by 312
Hansotia, T., Baggio, L. L., Delmeire, D., Hinke, S. A., Yamada, Y., Tsukiyama, K., Seino, Y., Holst, J. J., Schuit, F., & Drucker, D. J. (2004) · Diabetes · doi:10.2337/diabetes.53.5.1326 · Cited by 309
Self-citationDeacon, C. F. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.10.3575 · Cited by 301
Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV
Drucker, D. J., Shi, Q., Crivici, A., Sumner-Smith, M., Tavares, W., Hill, M., DeForest, L., Cooper, S., & Brubaker, P. L. (1997) · Nature Biotechnology · doi:10.1038/nbt0797-673 · Cited by 276
Self-citationNikolaidis, L. A., Elahi, D., Shen, Y.-T., & Shannon, R. P. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00347.2005 · Cited by 274
Durinx, C., Lambeir, A., Bosmans, E., Falmagne, J., Berghmans, R., Haemers, A., Scharpé, S., & De Meester, I. (2000) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.2000.01634.x · Cited by 267
Pederson, R. A., White, H. A., Schlenzig, D., Pauly, R. P., McIntosh, C. H. S., & Demuth, H.-U. (1998) · Diabetes · doi:10.2337/diab.47.8.1253 · Cited by 267
Bergman, A. J., Stevens, C., Zhou, Y., Yi, B., Laethem, M., De Smet, M., Snyder, K., Hilliard, D., Tanaka, W., Zeng, W., et al. (2006) · Clinical Therapeutics · doi:10.1016/j.clinthera.2006.01.015 · Cited by 265
Christopherson, K. W., Hangoc, G., & Broxmeyer, H. E. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.7000 · Cited by 240
Pospisilik, J. A., Stafford, S. G., Demuth, H.-U., Brownsey, R., Parkhouse, W., Finegood, D. T., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.4.943 · Cited by 232
The Role of Dipeptidyl Peptidase IV in the Cleavage of Glucagon Family Peptides
Zhu, L., Tamvakopoulos, C., Xie, D., Dragovic, J., Shen, X., Fenyk-Melody, J. E., Schmidt, K., Bagchi, A., Griffin, P. R., Thornberry, N. A., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212355200 · Cited by 221
Balkan, B., Kwasnik, L., Miserendino, R., Holst, J. J., & Li, X. (1999) · Diabetologia · doi:10.1007/s001250051445 · Cited by 209
Raun, K., von Voss, P., Gotfredsen, C. F., Golozoubova, V., Rolin, B., & Knudsen, L. B. (2007) · Diabetes · doi:10.2337/db06-0565 · Cited by 207
Hyperglycaemia increases dipeptidyl peptidase IV activity in diabetes mellitus
Mannucci, E., Pala, L., Ciani, S., Bardini, G., Pezzatini, A., Sposato, I., Cremasco, F., Ognibene, A., & Rotella, C. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1749-8 · Cited by 206
Reimer, M., Holst, J., & Ahren, B. (2002) · European Journal of Endocrinology · doi:10.1530/eje.0.1460717 · Cited by 195
Improved glucose tolerance and insulin secretion by inhibition of dipeptidyl peptidase IV in mice
Ahrén, B., Holst, J. J., Mårtensson, H., & Balkan, B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00600-2 · Cited by 193
Circulating CD26 Is Negatively Associated with Inflammation in Human and Experimental Arthritis
Busso, N., Wagtmann, N., Herling, C., Chobaz-Péclat, V., Bischof-Delaloye, A., So, A., & Grouzmann, E. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62266-3 · Cited by 191
In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans1
Hartmann, B., Harr, M. B., Jeppesen, P. B., Wojdemann, M., Deacon, C. F., Mortensen, P. B., & Holst, J. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.8.6717 · Cited by 191
Eltzschig, H. K., Faigle, M., Knapp, S., Karhausen, J., Ibla, J., Rosenberger, P., Odegard, K. C., Laussen, P. C., Thompson, L. F., & Colgan, S. P. (2006) · Blood · doi:10.1182/blood-2006-02-001016 · Cited by 188
Ryskjær, J., Deacon, C. F., Carr, R. D., Krarup, T., Madsbad, S., Holst, J., & Vilsbøll, T. (2006) · European Journal of Endocrinology · doi:10.1530/eje.1.02221 · Cited by 181
Abbott, C. A., McCaughan, G. W., Baker, E., & Sutherland, G. R. (1994) · Immunogenetics · doi:10.1007/bf01246674 · Cited by 177
Frohman, L. A., Downs, T. R., Heimer, E. P., & Felix, A. M. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114049 · Cited by 177
Vahl, T. P., Paty, B. W., Fuller, B. D., Prigeon, R. L., & D’Alessio, D. A. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021479 · Cited by 173
Wesley, U. V., McGroarty, M., & Homoyouni, A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1852 · Cited by 166
Sudre, B., Broqua, P., White, R. B., Ashworth, D., Evans, D. M., Haigh, R., Junien, J.-L., & Aubert, M. L. (2002) · Diabetes · doi:10.2337/diabetes.51.5.1461 · Cited by 165
Deacon, C., Danielsen, P. B., Klarskov, L., Olesen, M., & Holst, J. (2001) · Diabetes · doi:10.2337/diabetes.50.7.1588 · Cited by 155
Pospisilik, J. A., Stafford, S. G., Demuth, H., McIntosh, C. H. S., & Pederson, R. A. (2002) · Diabetes · doi:10.2337/diabetes.51.9.2677 · Cited by 138
Hartmann, B., Thulesen, J., Kissow, H., Thulesen, S., Ørskov, C., Röpke, C., Poulsen, S. S., & Holst, J. J. (2000) · Endocrinology · doi:10.1210/endo.141.11.7752 · Cited by 134
CD26/dipeptidyl peptidase IV and its role in cancer.
Pro, B., & Dang, N. H. (2004) · PubMed · doi:10.14670/hh-19.1345 · Cited by 115
Lambeir, A., Durinx, C., Proost, P., Damme, J. V., Scharpé, S., & Meester, I. D. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02982-9 · Cited by 114
Dipeptidyl peptidase IV activity and/or structure homologues (DASH) and their substrates in cancer
Bušek, P., Malík, R., & Šedo, A. (2003) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(03)00262-0 · Cited by 111
Åhrén, B., & Hughes, T. E. (2004) · Endocrinology · doi:10.1210/en.2004-1174 · Cited by 108
Meier, J. J., Gethmann, A., Nauck, M. A., Götze, O., Schmitz, F., Deacon, C. F., Gallwitz, B., Schmidt, W. E., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00576.2005 · Cited by 104
Deacon, C. F., Plamboeck, A., Møller, S., & Holst, J. J. (2002) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00452.2001 · Cited by 104
Thompson, N. L., Hixson, D. C., Callanan, H. M., Panzica, M. A., Flanagan, D. L., Faris, R. A., Hong, W., Hartel-Schenk, S., & Doyle, D. J. (1991) · Biochemical Journal · doi:10.1042/bj2730497 · Cited by 102
Pauly, R. P., Demuth, H., Rosche, F., Schmidt, J., White, H. A., Lynn, F. C., McIntosh, C. H. S., & Pederson, R. A. (1999) · Metabolism · doi:10.1016/s0026-0495(99)90090-2 · Cited by 102
Gault, V. A., Parker, J. C., Harriott, P., Flatt, P. R., & O'Harte, F. P. M. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1750525 · Cited by 102
Peranteau, W. H., Endo, M., Adibe, O. O., Merchant, A. M., Zoltick, P. W., & Flake, A. W. (2006) · Blood · doi:10.1182/blood-2006-04-018986 · Cited by 99
Frerker, N., Wagner, L., Wolf, R., Heiser, U. F., Hoffmann, T., Rahfeld, J., Schade, J., Karl, T., Naim, H. Y., Alfalah, M., et al. (2007) · Peptides · doi:10.1016/j.peptides.2006.09.027 · Cited by 99
Yan, S., Marguet, D., Dobers, J., Reutter, W. G., & Fan, H. (2003) · European Journal of Immunology · doi:10.1002/eji.200323469 · Cited by 97
Effects of dipeptidyl peptidase IV on the satiety actions of peptide YY
Unniappan, S., McIntosh, C. H. S., Demuth, H. U., Heiser, U. F., Wolf, R., & Kieffer, T. J. (2006) · Diabetologia · doi:10.1007/s00125-006-0310-8 · Cited by 91
In Vivo and in Vitro Degradation of Glucagon-Like Peptide-2 in Humans
Hartmann, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.8.2884 · Cited by 84
Ohnuma, K., Yamochi, T., Uchiyama, M., Nishibashi, K., Iwata, S., Hosono, O., Kawasaki, H., Tanaka, H., Dang, N. H., & Morimoto, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.17.7743-7757.2005 · Cited by 78
Ikushima, H., Munakata, Y., Iwata, S., Ohnuma, K., Kobayashi, S., Dang, N. H., & Morimoto, C. (2002) · Cellular Immunology · doi:10.1016/s0008-8749(02)00010-2 · Cited by 70
Metabolism of glucagon by dipeptidyl peptidase IV (CD26)
Pospisilik, J. A., Hinke, S. A., Pederson, R. A., Hoffmann, T., Rosche, F., Schlenzig, D., Glund, K., Heiser, U. F., McIntosh, C. H. S., & Demuth, H. (2001) · Regulatory Peptides · doi:10.1016/s0167-0115(00)00170-1 · Cited by 70
GIP-(3–42) does not antagonize insulinotropic effects of GIP at physiological concentrations
Deacon, C. F., Plamboeck, A., ROSENKILDE, M. M., de Heer, J., & Holst, J. J. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00577.2005 · Cited by 70
The Binding Site of Human Adenosine Deaminase for Cd26/Dipeptidyl Peptidase IV
Richard, E., Arredondo-Vega, F. X., Santisteban, I., Kelly, S. J., Patel, D. D., & Hershfield, M. S. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.9.1223 · Cited by 68
Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Physiology & Behavior · doi:10.1016/s0031-9384(03)00229-4 · Cited by 59
Grouzmann, E., Monod, M., Landis, B. N., Wilk, S., Brakch, N., Nicoucar, K., Giger, R., Malis, D. D., Szalay‐Quinodoz, I., Cavadas, C., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0939fje · Cited by 59
Tsuji, E., Misumi, Y., Fujiwara, T., Takami, N., Ogata, S., & Ikehara, Y. (1992) · Biochemistry · doi:10.1021/bi00162a035 · Cited by 57
Enteroinsular axis of db/db mice and efficacy of dipeptidyl peptidase IV inhibition
Nagakura, T., Yasuda, N., Yamazaki, K., Ikuta, H., & Tanaka, I. (2003) · Metabolism · doi:10.1053/meta.2003.50014 · Cited by 55
Yasuda, N., Nagakura, T., Yamazaki, K., Inoue, T., & Tanaka, I. (2002) · Life Sciences · doi:10.1016/s0024-3205(02)01637-5 · Cited by 52
Karl, T., Chwalisz, W. T., Wedekind, D., Hedrich, H. J., Hoffmann, T., Jacobs, R., Pabst, R., & von Hörsten, S. (2003) · Regulatory Peptides · doi:10.1016/s0167-0115(03)00149-6 · Cited by 50
CD26 modulates nociception in mice via its dipeptidyl-peptidase IV activity
Guieu, R., Fenouillet, E., DEVAUX, C., Fajloun, Z., Carrega, L., Sabatier, J., Sauze, N., & Marguet, D. (2005) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.003 · Cited by 49
Zander, M., Madsbad, S., Deacon, C. F., & Holst, J. J. (2005) · Diabetologia · doi:10.1007/s00125-005-0098-y · Cited by 45
Karl, T., Hoffmann, T., Pabst, R., & von Hörsten, S. (2003) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(03)00154-0 · Cited by 44
Yacoubi, M. E., Vaugeois, J., Marguet, D., Sauze, N., Guieu, R., Costentin, J., & Fenouillet, E. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2006.04.003 · Cited by 38
Rolin, B., Deacon, C. F., Carr, R. D., & Åhrén, B. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.05.013 · Cited by 37
Erickson, R. H., Suzuki, Y., Sedlmayer, A., et al. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)36657-8 · Cited by 32
Mitani, H., Takimoto, M., & Kimura, M. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.88.451 · Cited by 28
Faidley, T. D., Leiting, B., Pryor, K. D., Lyons, K., Hickey, G. J., & Thompson, D. R. (2006) · Experimental Biology and Medicine · doi:10.1177/153537020623100811 · Cited by 17
Cited by
Glucagon-like peptide 1 (GLP-1)
Müller, T. D., Finan, B., Bloom, S. R., D'Alessio, D., Drucker, D. J., Flatt, P. R., Fritsche, A., Gribble, F., Grill, H. J., Habener, J. F., et al. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.09.010 · Cited by 1,868
Self-citationTrends in insulin resistance: insights into mechanisms and therapeutic strategy
Li, M., Chi, X., Wang, Y., Setrerrahmane, S., Xie, W., & Xu, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01073-0 · Cited by 939
Muraki, I., Imamura, F., Manson, J. E., Hu, F. B., Willett, W. C., van Dam, R. M., & Sun, Q. (2013) · BMJ · doi:10.1136/bmj.f5001 · Cited by 544
Cardiovascular Biology of the Incretin System
Ussher, J. R., & Drucker, D. J. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1052 · Cited by 530
Self-citationPhysiology of Proglucagon Peptides: Role of Glucagon and GLP-1 in Health and Disease
Sandoval, D. A., & D'Alessio, D. A. (2015) · Physiological Reviews · doi:10.1152/physrev.00013.2014 · Cited by 498
Metadata
- Authors
- Drucker, D. J.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2007-06-01
- Volume
- 30
- Issue
- 6
- Pages
- 1335-1343
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- OpenAlex
- W2128325179
- Cited by
- 367
- References
- 79
- FWCI
- 15.49
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.